Morgan Stanley Raises Price Target for Align Technology to $169
ByAinvest
Friday, Feb 6, 2026 3:24 pm ET1min read
ALGN--
Morgan Stanley raises price target for Align Technology (ALGN) to $169, a 9.74% increase, and maintains an Equal-Weight rating. This adjustment reflects a positive outlook for the company and its leading clear aligner product Invisalign, which dominates over 90% of the market. Analysts forecast an average target price of $183.41, indicating an upside of 13.71% from the current price. The estimated GF Value for ALGN in one year is $264.21, suggesting a potential upside of 63.8% from the current price.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet